Analyst Research

Report Title Price
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Plunkett Research, Ltd.
$99.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Omni Bio Pharmaceutical Inc Announces Change Of Chairman-Form 8-K


Thursday, 15 Aug 2013 09:02am EDT 

Omni Bio Pharmaceutical Inc reported in its Form 8-K that on August 9, 2013, Vicki Barone and Steven Bathgate announced their intentions to resign as members of the Board of Directors of the Company) effective August 14, 2013. Ms. Barone was serving as the Chairperson of the Board and as a member of the Audit Committee. Both Ms. Barone and Mr. Bathgate are resigning for personal reasons and are not resigning because of a disagreement with the Company or on any matter relating to its operations, policies or practices. Effective August 13, 2013, Bruce Schneider, the Company’s CEO, was appointed as the Chairman of the Company’s Board of Directors. 

Latest Developments for Omni Bio Pharmaceutical Inc

Company Quote

0.17
-0.03 -15.00%
21 Oct 2014